Jue-Yeon Lee

This inventor holds 1 USPTO granted patent. Top assignee: Nibec Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jue-Yeon Lee. Retrieved from https://idiyas.com/inventor/jue-yeon-lee-ng42ockx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jue-Yeon Lee: Innovator in Peptide Research

Introduction

Jue-Yeon Lee is a notable inventor recognized for his contributions to the field of peptide research. He has made significant strides in developing innovative solutions for various health-related challenges. His work focuses on the inhibition of functions and expressions of multiple disease biomarkers.

Latest Patents

Jue-Yeon Lee holds a patent titled "Novel Use of Peptide for Inhibiting Functions and Expressions of Multiple Disease Biomarkers." This patent highlights his innovative approach to utilizing peptides in medical applications, showcasing his expertise and commitment to advancing healthcare solutions. He has 1 patent to his name.

Career Highlights

Currently, Jue-Yeon Lee is associated with Nibec Co., Ltd., where he continues to push the boundaries of peptide research. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking projects.

Collaborations

Throughout his career, Jue-Yeon Lee has worked alongside talented colleagues, including Chong-Pyoung Chung and Yoon Jeong Park. These collaborations have fostered a dynamic environment for innovation and research.

Conclusion

Jue-Yeon Lee's work in peptide research exemplifies the impact of innovative thinking in addressing complex health issues. His contributions are paving the way for future advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…